Skip to main content
. 2020 Feb 21;27(8):2417–2432. doi: 10.1038/s41418-020-0512-5

Fig. 1. IAP antagonist Birinapant sensitises a subset of melanoma cell lines to IZI1551-induced apoptosis.

Fig. 1

a Melanoma cell lines respond heterogeneously to single and combination treatment of IZI1551 and Birinapant. Cells were treated for 72 h followed by flow cytometric determination of cell death (propidium iodide positivity). Data shown are means from n = 3 independent experiments. b Synergy scores for treatment combinations, as calculated by Webb’s fractional product method. c Treatment-induced changes in IAP amounts, analysed by Western blotting. Actin served as loading control. Asterisks indicate unspecific bands. Representative results from n = 3 independent experiments are shown. d Apoptotic signalling was studied 24 h after single and combination treatment with IZI1551, Birinapant and Q-VD-OPh (30 µM). Actin served as a loading control. Representative results from n = 3 independent experiments are shown. e Melanoma cell lines die by apoptosis upon combination treatment. Cell lines were treated with 1 nM IZI1551, 1 µM Birinapant, with or without 30 µM Q-VD-OPh. Cells were stained with PI and Annexin V-APC and analysed by flow cytometry. Shown are mean values + SD of three independent experiments.